Anti JAKS

Alopecia hope in common arthritis drug

Flare rates low after covid vax

Promising findings on steroid-sparing options for PMR and GCA

Updated covid treatment guidelines and immunosuppressed patients

Real-world data on JAKi and CV outcomes

Rheumatology Republic Year in Review

JAKi: To cycle or switch?

What’s on the way for GCA?
